The UF Office of Clinical Research has published COVID-19 guidance for clinical research projects, which applies to all UF health-related human subjects research. See https://clinicalresearch.ctsi.ufl.edu/covid-19. Questions or Comments? Please contact OCR.
UF clinical Human Subjects Research encounters will continue to follow current masking and PPE guidelines published on the UF Health Bridge.
Effective immediately, UF Research will adopt the UF Campus COVID-19 Guidelines found at https://coronavirus.ufl.edu/resources/health-guidance/ as the requirements for UF research activities, with the exception of certain human subject research. The previous requirements within the Research Resumption Plan, implemented last spring at the height of the pandemic, regarding limited numbers of persons…
UF departments and researchers can purchase PPE for their research teams and research labs through UF Procurement Services. Ordering information can be found at https://procurement.ufl.edu/covid19ppe/. Items available include: Disposable Face CoveringReusable Face CoveringFloor DecalsHand SanitizerDisinfectantDisinfectant WipesSanitizing WipesFace ShieldsEye Protection…
The University of Florida has now begun Stage 3 in the process for reengaging on-campus research activities which have been interrupted by the COVID-19 pandemic.
UF|Research and OCR have each recently provided UF-specific research resumption guidance. The information in this webinar should not to be used to conflict with UF Guidance, but there may be useful information shared that we can all glean something from. Additionally, there are possible CE’s for certain accrediting organizations if there is an interest there.
The University of Florida has now begun Stage 2 in the process for reengaging on-campus research activities which have been interrupted by the COVID-19 pandemic.
The University of Florida is beginning the process for reengaging on-campus research activities which have been interrupted by the COVID-19 pandemic.
UF Health Investigational Drug Services has developed a position statement on the issue of shipping dispensed Rx to research participants.
The UF Institutional Biosafety Committee has issued guidance regarding important biosafety rules and regulations pertaining to COVID-19.